-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on CVS Health, Lowers Price Target to $104

Benzinga·11/05/2026 20:13:09
Listen to the news
Leerink Partners analyst Michael Cherny maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $112 to $104.